Tardive Dyskinesia

• FDA label_change · 2026-04-08
  FDA Approved: INGREZZA SPRINKLE — Supplemental Application (Neurocrine Biosciences, Inc.)

  FDA approved a supplemental application to add INGREZZA SPRINKLE (valbenazine) as a sprinkle formulation for tardive dyskinesia, including u…

• FDA label_change · 2024-11-26
  FDA Approved: AUSTEDO — Supplemental Application (Teva Neuroscience, Inc.)

  FDA approved a supplemental application for AUSTEDO (deutetrabenazine) from Teva Neuroscience, Inc., updating the product labeling.

• FDA label_change · 2019-07-15
  FDA Approved: AUSTEDO — Supplemental Application (Teva Neuroscience, Inc.)

  The FDA approved Teva's supplemental application for Austedo (deutetrabenazine) to update the product labeling. This likely reflects changes…

• FDA label_change · 2018-06-06
  FDA Approved: AUSTEDO — Supplemental Application (Teva Neuroscience, Inc.)

  FDA approved a supplemental application for AUSTEDO (deutetrabenazine) filed by Teva Neuroscience, updating the drug's labeling.